Diabetes, Vol 45, Issue 12 1720-1728, Copyright © 1996 by American Diabetes Association

ARTICLES

Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study

PJ Bingley
Department of Diabetes and Metabolism, St. Bartholomew's Hospital, London, U.K.

Many studies have examined the role of age, islet cell antibodies (ICAs), insulin autoantibodies (IAAs), and first-phase insulin responses (FPIRs) to an intravenous glucose tolerance test (IVGTT) as markers of risk of progression to IDDM, but a large data set is required for the analysis of the interactions between these markers. The Islet Cell Antibody Register Users Study (ICARUS) register includes 456 first-degree relatives with ICA levels > or = 5 JDF U confirmed in a reference laboratory, 108 of whom have progressed to IDDM in the course of prospective follow-up. Analysis of this data set confirmed the importance of the loss of FPIR, high ICA titer, coexistence of IAA, and young age in enhancing the risk of progression to the disease. The influence of any given marker of risk is modified by the presence or absence of the other markers. Cox regression analysis performed in a subset of 217 subjects for whom IVGTT, ICA, and IAA data were available showed that risk was most strongly associated with loss of FPIR; IAA and ICA titer contributed equally to the model, while age was also an independent risk determinant.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Mrena, S. M. Virtanen, P. Laippala, P. Kulmala, M.-L. Hannila, H. K. Akerblom, M. Knip, and the Childhood Diabetes in Finland Study Group Models for predicting type 1 diabetes in siblings of affected children. Diabetes Care, March 1, 2006; 29(3): 662 - 667. [Abstract] [Full Text] [PDF]

				N. A. Sherry, E. B. Tsai, and K. C. Herold Natural History of {beta}-Cell Function in Type 1 Diabetes Diabetes, December 1, 2005; 54(suppl_2): S32 - S39. [Abstract] [Full Text] [PDF]

				L. C. Harrison, M. C. Honeyman, C. E. Steele, N. L. Stone, E. Sarugeri, E. Bonifacio, J. J. Couper, and P. G. Colman Pancreatic {beta}-Cell Function and Immune Responses to Insulin After Administration of Intranasal Insulin to Humans At Risk for Type 1 Diabetes Diabetes Care, October 1, 2004; 27(10): 2348 - 2355. [Abstract] [Full Text] [PDF]

				J. P. Krischer, D. D. Cuthbertson, and C. Greenbaum Male Sex Increases the Risk of Autoimmunity but not Type 1 Diabetes Diabetes Care, August 1, 2004; 27(8): 1985 - 1990. [Abstract] [Full Text] [PDF]

				P. Achenbach, K. Warncke, J. Reiter, H. E. Naserke, A. J.K. Williams, P. J. Bingley, E. Bonifacio, and A.-G. Ziegler Stratification of Type 1 Diabetes Risk on the Basis of Islet Autoantibody Characteristics Diabetes, February 1, 2004; 53(2): 384 - 392. [Abstract] [Full Text] [PDF]

				C. J. Greenbaum and L. C. Harrison Guidelines for Intervention Trials in Subjects With Newly Diagnosed Type 1 Diabetes Diabetes, May 1, 2003; 52(5): 1059 - 1065. [Full Text] [PDF]

				C. J. Greenbaum, R. L. Prigeon, and D. A. D'Alessio Impaired {beta}-Cell Function, Incretin Effect, and Glucagon Suppression in Patients With Type 1 Diabetes Who Have Normal Fasting Glucose Diabetes, April 1, 2002; 51(4): 951 - 957. [Abstract] [Full Text] [PDF]

				B. Brooks-Worrell, V. H. Gersuk, C. Greenbaum, and J. P. Palmer Intermolecular Antigen Spreading Occurs During the Preclinical Period of Human Type 1 Diabetes J. Immunol., April 15, 2001; 166(8): 5265 - 5270. [Abstract] [Full Text] [PDF]

				P. P.L. Chiu, D. V. Serreze, and J. S. Danska Development and Function of Diabetogenic T-cells in B-cell-Deficient Nonobese Diabetic Mice Diabetes, April 1, 2001; 50(4): 763 - 770. [Abstract] [Full Text]

				C. J. Greenbaum, D. Cuthbertson, and J. P. Krischer Type 1 Diabetes Manifested Solely by 2-h Oral Glucose Tolerance Test Criteria Diabetes, February 1, 2001; 50(2): 470 - 476. [Abstract] [Full Text]

				C. J. Greenbaum, D. A. Schatz, D. Cuthbertson, A. Zeidler, G. S. Eisenbarth, and J. P. Krischer Islet Cell Antibody-Positive Relatives with Human Leukocyte Antigen DQA10102, DQB10602: Identification by the Diabetes Prevention Trial-Type 1 J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1255 - 1260. [Abstract] [Full Text]

				D. J. Becker, R. E. LaPorte, I. Libman, M. Pietropaolo, and H.-M. Dosch Prevention of Type 1 Diabetes: Is Now the Time? J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 498 - 506. [Full Text]

				A. Lernmark Type 1 Diabetes Clin. Chem., August 1, 1999; 45(8): 1331 - 1338. [Abstract] [Full Text] [PDF]